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T-cell responses against infected and cancer cells are
initiated by recognition of HLA-I peptides (the pepti-
dome) presented on the surface of nucleated cells. The
repertoire of HLA-I peptides originates primarily from
sampling the cytosolic degradation products of intracel-
lular proteins. HLA-I peptides have been extensively
studied in the last years because of their immediate use
as immunotherapy based cancer vaccines. Even more
advanced cell based therapeutic applications are being
developed based on cancer specific HLA-I peptides. In this
study, we used high resolution mass spectrometry and the
MaxQuant bioinformatics environment to obtain a high
accuracy and in-depth coverage of HLA peptidomes.
HLA-I peptidomes were immuno-affinity purified from 10
cancer and primary cell lines. The unprecedented high
number of thousands of identified HLA-I peptides per cell
line enabled us to evaluate the known mechanisms gov-
erning peptidome presentation and to determine the pro-
teome which is sampled for presentation. We envision
that applying our methodology for analysing patients
tumour samples will result in the discovery of new cancer
specific peptides. Better immunotherapeutic modules
could possibly be developed based on wider and more
accurate repertoires of HLA-I peptides and they will
increase the accessibility of these therapies for a larger
cohort of patients.
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